Adjuvant chemoradiotherapy

RADIATION9 trials

Conditions

Adjuvant ChemoradiotherapyEsophageal CancerGastric AdenocarcinomaHead and Neck Squamous Cell CarcinomaPancreatic CancerRectal CancerResectable Pancreatic CancerSurgery

Phase 1

Organ-Preserving Endoscopic Resection & Adjuvant RADIO-immuno-chemotherapy for Esophageal Cancer

Active, not recruitingNCT05667298

University of ManitobaEsophageal Cancer

Start: 2023-03-01End: 2029-07-01Updated: 2026-05-11

Phase 2

Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer

NCT01463501

Zhejiang Cancer HospitalEsophageal Cancer

Start: 2011-10-31End: 2016-12-31Target: 60Updated: 2013-05-14

Pembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC

RecruitingNCT05272696

Guangdong Provincial People's HospitalHead and Neck Squamous Cell Carcinoma

Start: 2022-03-01End: 2026-01-01Target: 86Updated: 2025-07-01

Phase 3

Rectal Preserving Treatment for Early Rectal Cancer. A Multi-centred Randomised Trial of Radical Surgery Versus Adjuvant Chemoradiotherapy After Local Excision for Early Rectal Cancers

NCT02371304

Amsterdam UMC, location VUmcRectal Cancer

Start: 2015-10-31End: 2023-01-31Target: 302Updated: 2020-05-21

Adujvant CT+CRT vs Adujvant CT After D2 Resection for Locally Advanced Proximal Gastric Adenocarcinoma

NCT03973008

Zhejiang Cancer HospitalGastric Adenocarcinoma

Start: 2019-03-11End: 2025-05-31Target: 408Updated: 2019-06-04

Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)

RecruitingNCT06427447

Changhai HospitalPancreatic Cancer

Start: 2024-08-06End: 2029-06-30Target: 770Updated: 2025-02-04

Unknown Phase

Feasibility study of the adjuvant chemoradiotherapy for the patients with high-risk rectal submucosal invasive cancer after the local resection

Active, not recruitingJPRN-UMIN000016785

National Cancer Center Hospital Eastrectal cancer

Start: 2015-03-11Target: 35Updated: 2026-06-29

Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study

NCT04737551

Shanghai Zhongshan HospitalAdjuvant Chemoradiotherapy, Resectable Pancreatic Cancer, Surgery

Start: 2020-01-01End: 2023-12-31Target: 400Updated: 2021-02-04

Active Surveillance vs Adjuvant Chemoradiotherapy for Locally Resected Intermediate-Risk T1 Rectal Cancer

RecruitingNCT07669298

Medical University of GdanskRectal Cancer

Start: 2026-06-14End: 2037-06-01Target: 480Updated: 2026-06-25

2026-05-27

ADJUPANC protocol: a phase III study of adjuvant chemotherapy versus chemoradiotherapy for pancreatic cancer

Future Oncology2025-06-29

Neoadjuvant pembrolizumab/nab-paclitaxel/cisplatin in patients with locally advanced head and neck squamous cell carcinoma: A single-arm phase II study.

Journal of Clinical Oncology2024-06-012 citations

Efficacy of adjuvant chemoradiotherapy in patients with pancreatic ductal adenocarcinoma after surgery: A real-world study in high-volume pancreatic cancer center.

Journal of Clinical Oncology2023-06-01

Adjuvant SOX chemotherapy versus concurrent chemoradiotherapy after D2 radical resection of locally advanced esophagogastric junction (EGJ) adenocarcinoma: study protocol for a randomized phase III trial (ARTEG).

2021-10-302 citations

A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancer.

2016-07-2169 citations